- Chairman, CEO, Co-Founder, Nacuity Pharmaceuticals, Inc.
- Director, Private Access, Inc.
- Co-founder, Protom International
- Former Alcon Laboratories Board Member
David Wohlberg, esq.
- Vice-Chairman, Co-Founder, Nacuity Pharmaceuticals, Inc.
- Former President, ImmunoCellular Therapeutics, Inc.
- Managing Principal, Birtcher Anderson
Gerald D. Cagle, Ph.D.
- 31 years at Alcon Laboratories, including serving as Global Head R&D, Chief Scientific Officer and VP Regulatory Affairs
- Holds more than 20 issued patents and has authored numerous peer reviewed scientific articles
- Director, Aerie, Clearside Biomedical, GrayBug Drug Delivery and FFB-CRI
Robin Steele, J.D., LL.M.
- Director, Daré Bioscience, Inc. and Alveo Technologies, Inc.
- Former Senior Vice President, General Counsel, and Secretary of InterMune, Inc.
- Former Vice President of Legal Affairs for North America, Elan Pharmaceuticals
- Director, Alios Biopharma and Targanta Therapeutics
Benjamin R. Yerxa, Ph.D.
- CEO, Foundation Fighting Blindness and RD Fund
- Former President and Chief Scientific Officer, Envisia Therapeutics
- Former Chief Scientific Officer, Liquidia Technologies
- Former Vice President for Research and Development, Clearside Biomedical